OTC · HNORY
Consumer Cyclical · Specialty Retail
$15.62
Up+$0.00 (+0.00%)
Updated Aug 28, 2026, 10:02 PM
SID Score
5.4/10
Composite research score
Smart Money
46/100
Neutral
Price performance
1M range · 0 trading sessions · Daily adjusted prices
HNORY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning HNORY.
HNORY research
Company profile and research snapshot.
HARVEY NRMN HDGS UNSP/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 12, 2026 | MACQUARIE RESEARCH | Neutral | — |
| Jul 1, 2026 | BELL POTTER SECURITIES | Buy | — |
| May 20, 2026 | JEFFERIES | Hold | — |
| Mar 2, 2026 | MACQUARIE RESEARCH | Outperform | — |
| Mar 1, 2026 | MACQUARIE RESEARCH | Outperform | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Feb 18, 2025
The News Forum is launching a new weekly program called 'Outspoken' hosted by Jonathan Harvey. The show aims to provide a fresh perspective on Canadian politics, cutting through the noise and demanding accountability from those in power.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HNORY.
